Details for New Drug Application (NDA): 050565
✉ Email this page to a colleague
NDA 050565 describes COACTIN, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the COACTIN profile page.
The generic ingredient in COACTIN is amdinocillin. There are three drug master file entries for this compound. Additional details are available on the amdinocillin profile page.
The generic ingredient in COACTIN is amdinocillin. There are three drug master file entries for this compound. Additional details are available on the amdinocillin profile page.
Summary for 050565
| Tradename: | COACTIN |
| Applicant: | Roche |
| Ingredient: | amdinocillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050565
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 250MG/VIAL | ||||
| Approval Date: | Dec 21, 1984 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
| Approval Date: | Dec 21, 1984 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/VIAL | ||||
| Approval Date: | Dec 21, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
